Many Medicaid enrollees have restricted access to SGLT2 inhibitors, GLP-1 receptor agonists

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online April 22 in the Annals of Internal Medicine.
š Full Story

Luigi Loving Leftist Crashes Out On Elderly MAGA Couple In The Middle Of a Restaurant
- Review: Ryzen AI CPU makes this the fastest the Framework Laptop 13 has ever been - Andrew Cunningham
- Exploring the New Generative AI Features in Google Chrome - Sean George
- Our favorite budget earbuds are back on sale for $45 - Lawrence Bonk
- Parents give kids more melatonin than ever, with unknown long-term effects - Michael Schulson, Undark Magazine
- Wild story of 'Wild World': Man returns overdue record after 49 years, avoids $5K fine
- What I Wish I Knew About Atopic Dermatitis - Staff Author

We Tried India's Biggest Battery Phone!
- Healing the Hole: The Ozone's Road to Recovery
- TikTok's Commitment to Sustainability and Climate Literacy at COP28 - Bertha Stephens
- Jandaslot: The Favorite Slot Online Site Indonesian Players - seo
- Grisly Southern Gothic Crime Drama On Tubi Is A Bittersweet Story of Redemption - Robert Scucci
- Revolutionizing Holiday Shopping with Generative AI - Michael Terry
- Kanye West Breaks Down in Tears, Reveals The Shocking Reason His Wife Walked Away! - Isaiah Amos